0QNO
vs
S
Swiss Market Index
0QNO
Over the past 12 months, 0QNO has underperformed Swiss Market Index, delivering a return of -20% compared to Swiss Market Index's +7% growth.
Stocks Performance
0QNO vs Swiss Market Index
Performance Gap
0QNO vs Swiss Market Index
Performance By Year
0QNO vs Swiss Market Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Lonza Group AG
Glance View
Lonza Group AG is a life sciences company that makes and supplies ingredients, materials, and manufacturing services used in medicines and other health products. It does not sell to ordinary consumers; instead, it works behind the scenes for drug makers, biotech companies, and healthcare customers that need help developing or producing complex products. Its business is split between custom manufacturing and specialty ingredients. Lonza helps customers develop medicines and then produce them at scale, especially harder-to-make treatments such as biologics and cell and gene therapies. It also sells products and services used in pharmaceutical research, quality control, and the production of ingredients for nutrition and personal care. Lonza makes money by charging customers for contract development, manufacturing, and related services, along with sales of specialized ingredients and materials. What makes its model different is that it sits in a critical part of the drug supply chain: customers rely on Lonza for technical know-how, tightly controlled production, and the ability to make complex products that are difficult to produce in-house.
